Early Detection Saves Lives
Thousands of newborns in Delhi now have a brighter future thanks to the 'Anmol' initiative, a significant step by the Delhi government towards proactively
identifying genetic and congenital disorders. This program, established with an allocation of Rs 25 crore, provides 56 free diagnostic tests for newborns within the crucial first days after birth. The core idea is to capture conditions that might not show immediate symptoms but can lead to severe, irreversible damage if left untreated. Dr. Seema Kapoor, a key figure in establishing this program, highlights that early diagnosis is paramount, especially considering India's high birth rate, where timely intervention can save countless lives. The initiative aims to significantly curb preventable disabilities, offering affected children a chance at a normal, healthy life.
Scaling Up Newborn Screening
While newborn screening has existed in India on a smaller scale, Delhi's 'Anmol' project marks a paradigm shift by becoming one of the first large-scale state-led efforts. Previously, screening was limited, with Kerala's 'Shalabham' program being a notable exception. Dr. Kapoor mentions that Delhi had been conducting screening in a project mode for five years, with the expectation of eventual state ownership. The 'Anmol' program, however, operationalizes an expanded screening process, performing 56 simultaneous tests from a single blood sample. This comprehensive approach, utilizing advanced technologies like Tandem Mass Spectrometry (TMS), can detect a wide array of metabolic and genetic disorders, a significant leap from the limited tests typically offered by private hospitals.
The Power of a Blood Sample
The screening process under the 'Anmol' project is remarkably simple yet powerful. It requires just a few drops of blood, approximately 180 microlitres, collected on specialized filter paper. This minimal sample is then analyzed for over 50 different conditions. Dr. Kapoor explains that results are categorized as positive, ambiguous, or negative, with follow-up testing conducted for those in the ambiguous or positive categories. Beyond genetic and metabolic disorders, the program also incorporates point-of-care screening for hearing impairment and congenital heart disease, two major causes of early infant mortality. This integrated approach ensures a more holistic assessment of newborn health, addressing critical issues that could otherwise go undetected.
Bridging Gaps in Care
The implementation of 'Anmol' is poised to address significant gaps in early diagnosis and care, as noted by Dr. Harish Chillani. While mandatory in many Western nations, comprehensive newborn screening has been a challenge in India. Early detection, even when treatment options are limited, empowers families with knowledge about genetic causes and helps in planning future pregnancies. Conditions like hypothyroidism, affecting roughly 1 in 2,500 babies in India, are completely treatable with inexpensive medication, but irreversible brain damage can occur if not diagnosed early. Similarly, conditions like galactosemia can be managed by simple dietary changes. The program also aims to increase awareness among families and healthcare providers about these conditions and available treatments, potentially setting a new standard for newborn screening nationwide.
